Monroe Carell Jr. Children’s Hospital at Vanderbilt/CDC investigate mysterious liver disease in children
Apr. 26, 2022—Physicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are collaborating with the CDC and other hepatologists around the country to help figure out the origins of a mysterious liver disease affecting children ages 1 month to 16 years old.
Feb. 9, 2022—Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.
Dec. 7, 2021—Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).
Vanderbilt-Ingram Cancer Center calls for action to get cancer-preventing HPV vaccination back on track
May. 27, 2021—A significant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention.
Apr. 29, 2021—Bradley Malin, PhD, professor of Biomedical Informatics, Biostatistics and Computer Science, has been appointed to the Board of Scientific Counselors (BSC) of the National Center for Health Statistics (NCHS) of the U.S. Centers for Disease Control and Prevention (CDC) through 2024.